Skip to main content
OpenTrials

Clinical trial condition

Familial Hypercholesterolemia

Explore clinical trials studying Familial Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

78 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Familial Hypercholesterolemia trial results

Enrolling by invitation

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

NCT04798430

Conditions
Cardiovascular Disease With Mention of Arteriosclerosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +12 more
Locations
  • NorthShore University Health System Evanston, Illinois, United States
  • Sterling Research Group Cincinnati, Ohio, United States
  • The Lindner Research Center Cincinnati, Ohio, United States
  • Metabolic & Atherosclerosis Research Center (MARC) Cincinnati, Ohio, United States
View Trial Details
Active, not recruiting

An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH)

NCT06331195

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations
  • Hcor São Paulo, Brazil
  • OCARA Belém, Brazil
  • Centro Oncológico de Roraima Boa Vista, Brazil
  • Instituto de Cardiologia e Transplantes do DF Brasília, Brazil
View all 24 locations
View Trial Details
Active, not recruiting

Effect of Breastfeeding on Lipid Profile and Cardiovascular Risk Markers in Women With Familial Hypercholesterolemia

NCT05367310

Conditions
Behavior, Breast Feeding, Cardiovascular Diseases, +13 more
Locations
  • Centre of Cardiovascular Surgery and Transplantation Brno, Czechia
  • Third Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University Prague, Czechia
  • Department of Internal Medicine, Erasmus MC Cardiovascular Institute Rotterdam, Netherlands
  • Oslo University Hospital Oslo, Norway
View Trial Details
Completed

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

NCT05952856

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0093) Daphne, Alabama, United States
  • G&L Research ( Site 0043) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0087) Beverly Hills, California, United States
View all 168 locations
View Trial Details

Related conditions